The Application Notebook
The chemicals 2- and 4-methylimidazole (2-MI and 4-MI) are by-products produced during the manufacturing of caramel coloring ingredients used to darken food products such as carbonated beverages and soy sauce.
The chemicals 2- and 4-methylimidazole (2-MI and 4-MI) are by-products produced during the manufacturing of caramel coloring ingredients used to darken food products such as carbonated beverages and soy sauce. These two chemicals were revealed as probable carcinogens in studies performed by the National Toxicology Program (NTP) and other researchers (1,2). In addition, 4-MI is listed as a carcinogen by the California Office of Environmental Health Hazard Assessment (OEHHA) in January 2011 with a calculated No Significant Risk Level (NSRL) of 16 μg per person per day (3). Thus, the quantitation of these two carcinogens in foods is of particular importance for food safety and human health.
Conventional methods for identification of 2-MI and 4-MI in caramel color include gas chromatography methods which involve labor intensive procedures (4). Liquid chromatographic methods have also been reported for 4-MI analysis (5).
This study demonstrates simultaneous quantitation of 2- and 4-methylimidazoles in carbonated drinks by ultrahigh performance liquid chromatography tandem mass spectrometry (UHPLC MS-MS).
The analyses were performed on a Dionex UltiMate® 3000 Rapid Separation Liquid Chromatography UHPLC system. Separation was achieved on an Acclaim® Trinity™ P1 mixed-mode column (2.1 × 50 mm) with isocratic elution at 0.5 mL/min. The mobile phase consisted of 10% methanol in pH 5.7 ammonium acetate buffer (total buffer concentration at 5 mM). Column temperature was maintained at 15 °C. A Thermo Scientific TSQ Quantum Access™ with heated electrospray ionization source (HESI) was operated in selected reaction monitoring (SRM) mode with the settings listed with the chromatogram. Vaporizer temperature was set at 350 °C and capillary temperature was set at 200 °C. Sheath gas and auxiliary gas were both set at 60 arbitrary units.
Figure 1: SRM chromatograms of real samples. The chemical 4-MI is quantified at 396 ppb in original dark carbonated drink.
As shown in Figure 1 (right), two target analytes were baseline separated on the Trinity P1 column. Both analytes were observed with the same two SRM transitions with different responses; the SRM with stronger response was used for quantitation (Q-SRM) and the other was used for confirmation (C-SRM). The ratio of the two SRM responses was used as additional confirmation to avoid possible false positives. Figure 1 (left) also demonstrates the direct analysis of a diluted dark carbonated drink after ten-fold dilution with positive detection of 4-MI. This diluted sample was re-analyzed after spiking with 100 ppb of each 2-MI and 4-MI, with the result showing in Figure 1 (right).
UltiMate and Acclaim are registered trademarks and Trinity is a trademark of Dionex Corporation. TSQ Quantum Access is a trademark of Thermo Fisher Scientific.
(1) http://ntp.niehs.nih.gov/files/535_Web_Final.pdf (Accessed May, 2011).
(2) http://ntp.niehs.nih.gov/files/516final_web.pdf (Accessed May, 2011).
(3) http://oehha.ca.gov/prop65/law/pdf_zip/010711NSRLrisk4EI.pdf (Accessed May, 2011).
(4) R.A. Wilks, M.W. Johnson, A.J. Shingler, J. Agric. Food Chem. 25(3), 1077 (1977).
(5) C. Moretten, G. Crétier, H. Nigay, J. Rocca, J. Agric. Food Chem. (2011) (published online March 7, 2011, available at http://pubs.acs.org/doi/full/10.1021/jf104464f, accessed March, 2011).
Dionex Corporation
1228 Titan Way, P.O. Box 3603, Sunnyvale, CA 94088
tel. (408) 737-0700, fax (408) 730-9403
Website: www.dionex.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.